

Please try another search
International Stem Cell (OTCQB:ISCO): Q3 EPS of -$0.54Revenue of $1.85M (-4.6% Y/Y)Press ReleaseNow read: MyoKardia (MYOK) Presents At Stifel 2017 Healthcare Conference - SlideshowOriginal article
International Stem Cell (OTCQB:ISCO): Q2 EPS of -$0.25Revenue of $1.76M (-8.3% Y/Y)Press ReleaseNow read: KemPharm (KMPH) Presents At Canaccord Genuity 37th Annual Growth Conference -...
International Stem Cell (OTCQB:ISCO): Q1 EPS of -$0.78Revenue of $2.01M (+24.1% Y/Y)Press ReleaseNow read: ProQR reports Q1 resultsOriginal article
By Robert-Jan Bartunek and Ben Hirschler BRUSSELS/LONDON (Reuters) - Europe's top court has opened the door to certain stem cell patents in the European Union by ruling that an organism incapable of...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review